Tropical Medicine & International Health is a distinguished journal published by Wiley, dedicated to the exploration and dissemination of cutting-edge research in the fields of infectious diseases, parasitology, and public health. With a robust open-access option, the journal facilitates the widespread sharing of information critical to addressing health issues in tropical and international settings. Since its inception in 1996, it has established a significant presence in the academic community, as indicated by its impressive ranking in various Scopus categories, notably positioned in the Q1 quartile for Parasitology and Q2 for both Infectious Diseases and Public Health, reflecting its high influence within these domains. The journal's commitment to advancing knowledge on health challenges prevalent in tropical environments makes it an invaluable resource for researchers, healthcare professionals, and students alike who are dedicated to improving global health outcomes.

Welcome to Immuno, a pioneering open-access journal published by MDPI that serves as a key platform for the dissemination of innovative research in the fields of immunology, biochemistry, and genetics. Established in 2021, this journal has rapidly established itself within the academic community, currently ranking in the 53rd percentile in Medicine (miscellaneous) and 50th percentile in Biochemistry, Genetics, and Molecular Biology according to Scopus metrics. With a commitment to advancing our understanding of immune mechanisms and their applications in health and disease, Immuno is dedicated to publishing high-quality peer-reviewed articles that contribute valuable insights to both researchers and practitioners. Positioned in the heart of Switzerland, its global accessibility and diverse editorial board are a testament to its aim to promote knowledge exchange among scientists, practitioners, and students alike. Explore the latest discoveries and advancements in immunological research through Immuno, where your contributions help shape the future of this critical area of study.

JOURNAL OF BIOMEDICAL SCIENCE, published by BMC, is a premier Open Access journal dedicated to the rapid dissemination of research in the fields of biomedical science, encompassing crucial areas such as biochemistry, cell biology, clinical biochemistry, and more. Since its inception in 1993, the journal has established itself as a leading publication, currently boasting a remarkable impact factor and quality as evidenced by its Q1 quartile rankings across multiple categories in 2023. With an impressive track record, including a Scopus ranking in the top percentiles across several disciplines, it serves as a vital resource for researchers, professionals, and students who are keen on advancing their knowledge in biomedicine. The journal operates under a fully Open Access model, ensuring that all published articles are freely available to the global research community, thus contributing to the broader dissemination and accessibility of scientific knowledge. Based in the United Kingdom, JOURNAL OF BIOMEDICAL SCIENCE is committed to fostering innovation and collaboration in research, appealing to those aiming to make impactful contributions to the biomedical sphere.

Welcome to Advances in Clinical and Experimental Medicine, an esteemed publication by WROCLAW MEDICAL UNIVERSITY, dedicated to advancing the essential fields of clinical and experimental medicine. With an open access model since 2017, this journal ensures that researchers, healthcare professionals, and students worldwide can freely access high-quality scientific content. Covering a broad spectrum of topics including biochemistry, genetics, internal medicine, and pharmacology, Advances in Clinical and Experimental Medicine has established itself as a pivotal resource in the scientific community, currently holding prestigious rankings such as Q2 in Biochemistry, Genetics, and Molecular Biology (miscellaneous) and Q1 in Reviews and References (medical) for 2023. Spanning over two decades of rigorous research publication, the journal is a critical platform for sharing innovative findings and fostering collaboration among scholars, making it an invaluable asset for those at the forefront of medical science.

Lancet Regional Health - Southeast Asia, published by ELSEVIER, stands as a pivotal open-access journal established in 2022, dedicated to advancing regional health discourse across Southeast Asia. With its ISSN 2772-3682, this journal endeavors to provide a platform for high-quality research and innovative solutions in key areas such as Infectious Diseases, Psychiatry and Mental Health, and Public Health, Environmental and Occupational Health. Recognized for its exceptional quality, it has achieved Q1 rankings in these pressing categories, reflecting its commitment to publishing impactful findings that resonate with both the academic community and practitioners alike. The journal is vowed to fostering open access, enhancing the reach and applicability of its content to aid policy-making and community health advancements in the region. By facilitating access to groundbreaking research, Lancet Regional Health - Southeast Asia plays an essential role in shaping public health narratives and promoting collaboration among researchers, students, and healthcare professionals.

ANNALS OF EPIDEMIOLOGY, published by Elsevier Science Inc, stands as a leading journal in the field of epidemiology, with an impressive impact factor that reflects its significant contribution to public health research. With an ISSN of 1047-2797 and an E-ISSN of 1873-2585, the journal has been at the forefront of disseminating high-quality, peer-reviewed research since its inception in 1990. It is consistently ranked in the first quartile (Q1) for epidemiology in 2023, occupying the 29th position out of 148 in the Scopus Medicine category, with a percentage ranking in the 80th percentile. The journal aims to provide a comprehensive platform for the interdisciplinary exchange of pioneering epidemiological studies, exploring diverse health issues and their societal impacts. Researchers, professionals, and students alike will find valuable insights and innovative methodologies within its pages, making it an essential resource for anyone engaged in the study and application of epidemiology. Its headquarters located in the United States (STE 800, 230 Park Ave, New York, NY 10169) further reinforces its influence in the academic community.

Biomolecules and Biomedicine is a pioneering open-access journal dedicated to advancing the fields of molecular biology and biomedical sciences, published by the Association of Basic Medical Science Federation Bosnia & Herzegovina in Sarajevo. With the ISSN 2831-0896 and the E-ISSN 2831-090X, this journal aims to facilitate the dissemination of high-quality research from 2023 onwards, inviting submissions that provide innovative insights and findings across various facets of medicine and biological sciences. Positioned within the General Medicine and Biochemistry, Genetics and Molecular Biology categories, it currently holds rankings of 332 out of 636 and 173 out of 221 respectively, highlighting its emerging influence in these fields. As an open-access journal, it ensures that all published research is freely accessible to a global audience, fostering collaboration and knowledge exchange among researchers, professionals, and students alike. With a commitment to enhancing scientific discourse and promoting cutting-edge research, Biomolecules and Biomedicine is poised to become a vital resource for those dedicated to unraveling the complexities of biomolecules and their roles in health and disease.

Tropical Medicine and Health is a prestigious open-access journal published by BMC that serves as a vital platform for researchers and health professionals focusing on the fields of tropical medicine, infectious diseases, and public health. With an ISSN of 1348-8945 and an E-ISSN of 1349-4147, the journal has established itself in the academic community since its inception in 2004, bridging the gap between research and real-world applications in managing tropical diseases. Recognized for its quality, it holds a commendable Q2 ranking in both the Infectious Diseases and Public Health, Environmental and Occupational Health categories, positioned in the 2023 Scopus rankings within the 85th and 74th percentiles, respectively. Researchers can access high-quality, peer-reviewed articles that contribute significantly to advancing knowledge in the field. With a commitment to fostering open scientific dialogue, Tropical Medicine and Health is not just a journal, but a collaborative space for researchers, students, and practitioners working to improve health outcomes in tropical regions worldwide.

Revista da Sociedade Brasileira de Medicina Tropical is a distinguished open-access journal published by the Sociedade Brasileira de Medicina Tropical, focusing on the critical fields of Infectious Diseases, Microbiology, and Parasitology. Since its inception in 1972, this journal has committed to disseminating impactful research that addresses pressing global health challenges, particularly in tropical and infectious diseases prevalent in Brazil and beyond. With a robust publication history, it has been recognized as a Q3 journal in esteemed categories, reflecting its valuable contributions to scientific literature and its ranking in various Scopus categories, including a notable position in Parasitology. Researchers, professionals, and students are encouraged to engage with its rich repository of research, which has been freely accessible since 1997, fostering a wide-reaching impact on public health strategy and scientific innovation.

The Lancet Regional Health-Europe is a prestigious academic journal published by Elsevier, dedicated to advancing research in the fields of Health Policy, Internal Medicine, and Oncology. As part of a reputable series that focuses on regional health issues, it aims to publish high-quality, peer-reviewed articles that contribute to the understanding and improvement of health systems across Europe. With an impressive impact factor reflected in its Q1 quartile rankings for 2023—ranking #2 in Health Policy, #8 in Internal Medicine, and #22 in Oncology—it is recognized for its significant contribution to cutting-edge research. The journal offers open access options, ensuring that findings are widely disseminated and accessible to researchers, healthcare professionals, and policy-makers alike. By fostering collaboration and interdisciplinary discourse, The Lancet Regional Health-Europe serves as an essential platform for innovative solutions and strategies in health care that address the unique challenges faced within the European context, making it an invaluable resource for academics and practitioners dedicated to public health advancement.